Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/36127737http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/36127737http://www.w3.org/2000/01/rdf-schema#comment"

Background

PRDM5 is considered a tumor suppressor in several types of solid tumors and is involved in multiple cellular processes. However, target genes regulated by PRDM5 in lung cancer and its potential mechanism are poorly defined.

Methods

Survival analysis was conducted using Kaplan-Meier estimates based on the online databases. RNA-sequencing and bioinformatics analysis were performed to identify the differentially expressed genes in PRDM5-overexpressed A549 cells.

Results

We observed deregulated PRDM5 in several lung adenocarcinoma cell lines and its association with a poor prognosis. PRDM5 overexpression inhibited the proliferation of lung adenocarcinoma cells in vitro and suppressed tumor growth in a xenograft model. PRDM5 upregulated the promoter activity of SOCS1, which then inhibited the phosphorylation of JAK2 and STAT3.

Conclusions

Our study suggests that the low expression of PRDM5 promotes the proliferation of lung adenocarcinoma cells by downregulating SOCS1 and then upregulating the JAK2/STAT3 signaling pathway."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.org/dc/terms/identifier"doi:10.1002/cam4.5251"xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Fang L."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"He J."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Liu X."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Ma M."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Ren Y."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Wang Y."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Yang J."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Su C."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Ge L."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/author"Xin L."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/name"Cancer Med"xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/pages"4568-4578"xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/title"Deregulation of PRDM5 promotes cell proliferation by regulating JAK/STAT signaling pathway through SOCS1 in human lung adenocarcinoma."xsd:string
http://purl.uniprot.org/citations/36127737http://purl.uniprot.org/core/volume"12"xsd:string
http://purl.uniprot.org/citations/36127737http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/36127737
http://purl.uniprot.org/citations/36127737http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/36127737
http://purl.uniprot.org/uniprot/#_L0R6M5-mappedCitation-36127737http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36127737
http://purl.uniprot.org/uniprot/#_Q9NQX1-mappedCitation-36127737http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/36127737
http://purl.uniprot.org/uniprot/Q9NQX1http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/36127737
http://purl.uniprot.org/uniprot/L0R6M5http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/36127737